Skip to main content
logo
Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
11.32
+1.04 (10.12%)
At close: Mar 31, 2026, 4:00 PM EDT
11.10
-0.22 (-1.94%)
After-hours: Mar 31, 2026, 7:58 PM EDT

Korro Bio Revenue

In the year 2025, Korro Bio had annual revenue of $6.39M with 181.46% growth. Korro Bio had revenue of $1.29M in the quarter ending December 31, 2025, a decrease of -43.11%.

Revenue (ttm)
$6.39M
Revenue Growth
+181.46%
P/S Ratio
25.54
Revenue / Employee
$110,207
Employees
58
Market Cap
163.26M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.39M4.12M181.46%
Dec 31, 20242.27M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Heron Therapeutics154.90M
Precision BioSciences34.26M
Whitehawk Therapeutics7.15M
Cartesian Therapeutics2.80M
Molecular Partners AG856.30K
NeOnc Technologies Holdings59.99K
Revenue Rankings

KRRO News

More News